Skip to content
Compare stocks

China Resources Sanjiu Medical & Pharmaceutical vs Supernus stock comparison

Score, categories, valuation, dividend, crash risk and price performance of China Resources Sanjiu Medical & Pharmaceutical and Supernus side by side. Figures from the overnight run, closing prices from 19 Nov 2026.

Key figures compared

000999.SZChina Resources Sanjiu Medical & PharmaceuticalSUPNSupernus
MEQIRI Score
Score7562
Fundamentals8755
Growth8364
Profitability6792
Valuation7999
Technical analysis6534
Momentum5522
Stability9437
Capital allocation6888
Price and valuation
Closing price$3.95$28.35
Market cap$6.58B$5.89B
P/E13.67.7
Forward P/Eno datano data
Fair value$6.02$69.42
Fair value versus price+52.3%+144.9%
Growth and dividend
Revenue growth per year+18.3%+13.9%
Dividend yield3.8%0.0%
Risk and performance
Crash riskno datahigh36 in 100
Price 1 year−9.7%−13.0%
Price 5 years+83.4%+65.5%
IndustryDrug Manufacturers (Specialty & Generic)Drug Manufacturers (Specialty & Generic)

Score and figures from the overnight run, closing prices from 19 Nov 2026. Amounts in US dollars, converted at the ECB rate. Price performance without dividends. The comparison shows figures and is not a recommendation to buy.

Price performance

  • China Resources Sanjiu Medical & Pharmaceutical
  • Supernus

All lines start at 100 on 23 November 2021. Closing prices without dividends, each stock in its trading currency.

Questions and Answers

How do China Resources Sanjiu Medical & Pharmaceutical and Supernus compare on the MEQIRI Score?

The MEQIRI Score (0 to 100) is 75 for China Resources Sanjiu Medical & Pharmaceutical and 62 for Supernus. The category Stability differs most, with 94 for China Resources Sanjiu Medical & Pharmaceutical and 37 for Supernus. The score combines eight categories and is recalculated every night.

What is the P/E ratio of China Resources Sanjiu Medical & Pharmaceutical and Supernus?

China Resources Sanjiu Medical & Pharmaceutical: P/E 13.6, forward P/E no data. Supernus: P/E 7.7, forward P/E no data. As of the close on 19 Nov 2026.

What is the dividend yield of China Resources Sanjiu Medical & Pharmaceutical and Supernus?

China Resources Sanjiu Medical & Pharmaceutical: 3.8%. Supernus: 0.0%. Based on payments over the last twelve months.

What is the crash risk of China Resources Sanjiu Medical & Pharmaceutical and Supernus?

China Resources Sanjiu Medical & Pharmaceutical: no data. Supernus: Crash risk high (36 in 100). Crash risk means a fall of 30% or more within a year, measured in the backtest against companies of similar size.

Why does the price chart start at 100?

All lines start at 100 on the same day. That shows performance regardless of a stock's price: 150 means 50% more than at the start, 80 means 20% less.

Does the comparison tell me which stock to buy?

No. MEQIRI shows figures and explains them, but gives no buy recommendation and no price target. The score helps you see strengths and weaknesses faster.

More comparisons

Compare stocks